---
title: "Sekisui Chemical posts FY2026 Q1 earnings release for quarter ended June 30, 2026"
type: "News"
locale: "en"
url: "https://longbridge.com/en/news/294464139.md"
description: "Sekisui Chemical Co. Ltd. has released its earnings report for the first quarter of fiscal year 2026, covering the period ended June 30, 2026. The company published this financial disclosure on July 31, 2026."
datetime: "2026-07-31T06:34:40.000Z"
locales:
  - [zh-CN](https://longbridge.com/zh-CN/news/294464139.md)
  - [en](https://longbridge.com/en/news/294464139.md)
  - [zh-HK](https://longbridge.com/zh-HK/news/294464139.md)
generator: "portal-rs"
---

# Sekisui Chemical posts FY2026 Q1 earnings release for quarter ended June 30, 2026

-   Sekisui Chemical posted its earnings release for the three months ended June 30, 2026. \* Document URL: here Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Sekisui Chemical Co. Ltd. published the original content used to generate this news brief on July 31, 2026, and is solely responsible for the information contained therein. © Copyright 2026 - Public Technologies (PUBT) Original Document: here

### Related Stocks

- [4204.JP](https://longbridge.com/en/quote/4204.JP.md)

## Related News & Research

- [AgroGalaxy delays 2025 results release to Nov. 30, 2026](https://longbridge.com/en/news/297440664.md)
- [Enjoei updates financial events calendar for 2026](https://longbridge.com/en/news/297563694.md)
- [Vuxen Group announces availability of FY2025/2026 annual report (May 1, 2025–April 30, 2026)](https://longbridge.com/en/news/297499193.md)
- [Exmar announces availability of 2026 half-year results release](https://longbridge.com/en/news/296992548.md)
- [Eiffage announces availability of H1 2026 results report](https://longbridge.com/en/news/297066901.md)

---
> **Disclaimer: This article is for reference only and does not constitute any investment advice.**